ZNF382 and hepatocellular carcinoma: ZNF382 was frequently downregulated by promoter methylation in HBV-related HCCs relative to HBV-infected liver cirrhosis tissues and decreased expression of ZNF382 was strongly correlated with poor survival in early-stage HCC patients [27].